v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash flows from operating activities          
Net income (loss) $ 131,783 $ 99,795 $ 58,041 $ 157,980  
Adjustments to reconcile net income (loss) to net cash provided by operating activities:          
Provision for loss on receivables and retained interests in securitization trusts     (6,465) 4,850  
Depreciation and amortization     374 418  
Amortization of financing costs     7,412 7,895  
Equity-based expenses     23,736 18,272  
Equity method investments     14,774 (171,121)  
Non-cash gain on securitization     (32,709) (11,407)  
Loss on debt extinguishment     20,206 10,557  
Changes in receivables held-for-sale     1,019 (4,285)  
Changes in accounts payable, accrued expenses, and other     19,028 30,545  
Change in accrued interest on receivables and debt securities     (52,484) (27,371)  
Cash received (paid) upon hedge settlement     31,247 17,696  
Other     (516) 8,421  
Net cash provided by (used in) operating activities     83,663 42,450  
Cash flows from investing activities          
Equity method investments     (694,414) (299,980)  
Equity method investment distributions received     19,134 19,529  
Purchases of and investments in receivables ($62 million and $95 million related to equity method investees, respectively)     (301,681) (287,049)  
Principal collections from receivables ($124 million and $79 million from equity method investees, respectively)     343,834 172,080  
Proceeds from sales of receivables     15,282 8,344  
Purchases of debt securities and retained interests in securitization trusts     (7,457) (6,545)  
Collateral provided to hedge counterparties     0 (4,110)  
Collateral received from hedge counterparties     7,730 5,340  
Other     74,224 8,230  
Net cash provided by (used in) investing activities     (543,348) (384,161)  
Cash flows from financing activities          
Proceeds from credit facilities     657,000 395,000  
Principal payments on credit facilities     (702,000) (395,000)  
Proceeds from issuance of term loan     250,000 0  
Principal payments on term loan     (161,800) (11,124)  
Proceeds from (repayments of) commercial paper notes     (225,500) 256,500  
Proceeds from issuance of senior notes     1,395,260 996,174  
Principal payments on convertible notes     0 (200,000)  
Redemption of senior notes     (1,050,000) (700,000)  
Proceeds from issuances of junior subordinated notes     600,000 0  
Net proceeds of common stock issuances     0 119,876  
Payments of dividends and distributions     (112,657) (102,443)  
Redemption premium and fees paid     (17,942) (6,645)  
Payment of financing costs     (18,463) (7,195)  
Collateral provided to hedge counterparties     (41,370) (110,320)  
Collateral received from hedge counterparties     31,000 71,890  
Other     (3,322) (6,402)  
Net cash provided by (used in) financing activities     595,296 295,361  
Increase (decrease) in cash, cash equivalents, and restricted cash     135,611 (46,350)  
Cash, cash equivalents, and restricted cash at beginning of period     145,223 150,156 $ 150,156
Cash, cash equivalents, and restricted cash at end of period $ 280,834 $ 103,806 280,834 103,806 $ 145,223
Interest paid     153,803 146,497  
Supplemental disclosure of non-cash activity          
Interests retained from securitization transactions     22,290 18,662  
Removal of deferred financing obligation upon securitization     50,882 29,051  
Property, plant, and equipment received upon consolidation of a VIE     164,986 0  
Contract liability assumed upon consolidation of a VIE     25,000 0  
Receivables eliminated upon consolidation of a VIE     126,242 0  
Non-controlling interest added upon consolidation of a VIE     14,100 0  
Non-recourse debt          
Cash flows from financing activities          
Principal payments on non-recourse debt     $ (4,910) $ (4,950)